Puma therapeutics top
Puma therapeutics top
Puma therapeutics top
Puma therapeutics top
Puma therapeutics top
Puma therapeutics top

Puma therapeutics top

Puma therapeutics top, Puma Biotechnology begins Phase II trial of lung cancer drug top

$48.00

SKU: 7411422

Colour
  • Knight Therapeutics licences cancer drug from Puma Biotechnology
  • PUMA BIOTECHNOLOGY INC. FORM 8 K A Shareholder
  • Puma Biotech Rebranding Alex Maurer Designs
  • Proposed model for PUMA mediated apoptosis. PUMA P53 upregulated
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus